Skip to content
10-Q

Quarterly Report

AngioDynamics, Inc. ANGO

0001275187-25-000005

← back to feed
Filed
Jan 8, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jan 7, 2025 40.47M sh
Cash And Equivalents Q2 2025 · Nov 30, 2024 $54.09M
Cash And Equivalents Q2 2025 · May 31, 2024 $76.06M
Current Liabilities Q2 2025 · Nov 30, 2024 $88.6M
Current Liabilities Q2 2025 · May 31, 2024 $91.16M
Total Liabilities Q2 2025 · Nov 30, 2024 $104.78M
Total Liabilities Q2 2025 · May 31, 2024 $112.09M
Current Assets Q2 2025 · Nov 30, 2024 $175.36M
Current Assets Q2 2025 · May 31, 2024 $193.25M
Total Assets Q2 2025 · Nov 30, 2024 $291.55M
Total Assets Q2 2025 · May 31, 2024 $317.67M
Shares Diluted Q2 2025 · Nov 30, 2023 40.22M sh
Shares Diluted Q2 2025 · Nov 30, 2023 40.1M sh
Stock Repurchased Q2 2025 · Nov 30, 2023 $0
Capex Q2 2025 · Nov 30, 2023 $1.35M
Operating Cash Flow Q2 2025 · Nov 30, 2023 −$20.63M
Stockholders Equity Q2 2025 · Nov 30, 2023 $401.23M
Stockholders Equity Q2 2025 · Aug 31, 2023 $427.8M
Stockholders Equity Q2 2025 · May 31, 2023 $378.3M
Eps Diluted Q2 2025 · Nov 30, 2023 −$0.72
Eps Diluted Q2 2025 · Nov 30, 2023 $0.42
Eps Basic Q2 2025 · Nov 30, 2023 −$0.72
Eps Basic Q2 2025 · Nov 30, 2023 $0.42
Sga Expense Q2 2025 · Nov 30, 2023 $9.29M
Sga Expense Q2 2025 · Nov 30, 2023 $20.15M
Rd Expense Q2 2025 · Nov 30, 2023 $8.66M
Rd Expense Q2 2025 · Nov 30, 2023 $16.6M
Net Income Q2 2025 · Nov 30, 2023 −$29.05M
Net Income Q2 2025 · Nov 30, 2023 $16.84M
Net Income Q2 2025 · Aug 31, 2023 $45.88M
Operating Income Q2 2025 · Nov 30, 2023 −$13.12M
Operating Income Q2 2025 · Nov 30, 2023 $21.91M
Gross Profit Q2 2025 · Nov 30, 2023 $40.26M
Gross Profit Q2 2025 · Nov 30, 2023 $80.32M
Cost Of Revenue Q2 2025 · Nov 30, 2023 $38.81M
Cost Of Revenue Q2 2025 · Nov 30, 2023 $77.43M
Revenue Q2 2025 · Nov 30, 2023 $79.07M
Revenue Q2 2025 · Nov 30, 2023 $157.75M